Dr. Ralph and Marian Falk Medical Research Trust 2026 Catalyst Awards Program
Provides up to $350,000 in seed funding to support high-risk, high-reward translational research that addresses critical scientific and therapeutic roadblocks to be transferred to clinical practice.
Catalyst Awards provide an opportunity to conduct preliminary work on high-risk, high-reward research addressing a wide variety of clinical disease areas. The target of the Falk Catalyst Award’s funding are projects at the intersection of technology and clinical science, intended to move from basic science insights towards solutions, techniques, and tools that can be transferred to clinical practice in the near term. The Catalyst Research Award Program provides one to two years of seed funding to enable planning and development of projects,teams, tools,techniques, and management infrastructure necessary to successfully compete for two- to three-year awards through the Transformational Research Award Program. The work proposed in the Catalyst submission will serve to demonstrate the scientific promise, infrastructure, methods, and preliminary data in support of further transformational research.